Infectious Diseases II
| (b) | Retrospective cohort studies have found that patients with a reported penicillin or |
|---|
cephalosporin allergy had a higher odds of developing an SSI than those without a
reported allergy.
| (c) | Of note, cefazolin has a unique side chain and therefore has very low cross-reactivity with |
|---|
penicillin. The 2022 drug allergy practice parameter update states that in patients with a
history of anaphylaxis to penicillin, a structurally dissimilar R1 side chain cephalosporin
(e.g., cefazolin) can be administered routinely without prior testing (J Allergy Clin
Immunol. 2022;150(6):1333-1393).
iv.
Adjust dose of antibiotics for obesity β See Table 2 for suggested dosing.
Patients with known nasal carriage of S. aureus should receive intranasal applications
of mupirocin 2% ointment twice daily for up to 5 days before surgery with or without a
combination of chlorhexidine gluconate body wash.
vi.
Alcohol-based antiseptic solutions with chlorhexidine gluconate for surgical site skin preparation
should be used in patients undergoing surgical procedures.
vii.
Preoperative bowel preparation
| (a) | Although unaddressed by the CDC, preoperative bowel preparation before colorectal |
|---|
surgery was recommended by the ACS/SIS and WHO guidelines.
| (b) | A recent meta-analysis demonstrated that combined oral antibiotic prophylaxis combined |
|---|
with mechanical bowel preparation was associated with reduced SSI rates compared with
mechanical bowel preparation alone. Oral antibiotic prophylaxis was associated with
significant decreases in rates of anastomotic leak and 30-day mortality without increasing
rates of Clostridioides difficile infections.
| (c) | Combined bowel preparation with oral antibiotic prophylaxis and mechanical bowel |
|---|
preparation is recommended by the 2019 American Society of Colon and Rectal Surgeons
Clinical Practice Guidelines.
| d. | Intraoperative |
|---|
Re-dose antibiotics, if necessary β See Table 2 for dosing schedule during surgery.
ii.
In general, antibiotics with short half-lives should be re-dosed at a frequency of 2 times the
half-life of the agent. Antibiotics should also be re-dosed if there is significant intraoperative
blood loss.
iii.
Goal of re-dosing is to maintain bactericidal concentrations throughout the operation. It may
be prudent to consider re-dosing prophylaxis intraoperatively if large amounts of fluids and/or
transfusions are being administered.
iv.
Maintain normothermia. Two small randomized controlled trials showed that maintaining
normothermia reduced the risk of SSIs. The mechanism for this protective effect is currently
unknown; however, a hypothesis is that this effect may result from impaired neutrophil
function or subcutaneous vasoconstriction and subsequent tissue hypoxia with hypothermia.
Postoperative
Discontinue prophylactic antibiotics within 24 hours after non-cardiac surgery and within
48 hours after cardiac surgery. Drains are not a sufficient reason to continue prophylactic
antibiotics.
ii.
Early recovery after surgery (ERAS) protocols: Aim to reduce the stress of surgery on patients
by maintaining near normal physiology in the preoperative, intraoperative, and postoperative
phases of care.
| (a) | Early recovery after surgery protocols incorporate SSI prevention guideline |
|---|
recommendations, such as parenteral antibiotic prophylaxis and strict glycemic control,
as well as interventions with newer evidence, such as oral antibiotic prophylaxis with
mechanical bowel preparation, goal directed fluid therapy, and early enteral feeding.
| (b) | A meta-analysis of 27 randomized controlled trials assessing 3279 patients undergoing |
|---|
abdominal/pelvic surgery showed a significant reduction in postoperative SSI for patients
enrolled in ERAS pathways compared with conventional perioperative pathways.
Diagnosis, management, and treatment of SSIs: See Infectious Diseases I chapter.